Vaxcyte (PCVX) Stock Forecast & Price Target
Score
Vaxcyte, Inc. price target
| PCVX | |
|---|---|
| Low | $120.00 |
| Average | $122.33 |
| High | $125.00 |
| Upside vs current price | +93.0% |
The average target of $122.33 is +93.0% versus the current PCVX price of $63.37.
Vaxcyte, Inc. analyst ratings
| Rating | Analysts |
|---|---|
| Strong buy | 1 |
| Buy | 9 |
| Hold | 1 |
| Sell | 0 |
| Strong sell | 0 |
| Consensus | Buy |
11 analysts cover PCVX.
Vaxcyte, Inc. EPS and revenue estimates
PCVX shows the next fiscal years with at least three analysts: 2026 EPS $-8.23, 2027 EPS $-6.50. A thinner year is left off this table.
| Fiscal year | EPS estimate | Revenue estimate |
|---|---|---|
| 2026 | $-8.23 | $25.00M |
| 2027 | $-6.50 | $87.15M |
Is Vaxcyte, Inc. a buy or sell?
Of the 11 analysts covering Vaxcyte, Inc., 10 rate it a buy (1 strong buy and 9 buy), 1 rates it a hold, and 0 rate it a sell (0 sell and 0 strong sell).
The PCVX consensus label is Buy, beside 10 buy-side ratings and 0 sell-side ratings.
The average target of $122.33 implies +93.0% versus the current price of $63.37.
Those 11 ratings on PCVX are a headcount, and the label on file is Buy.
Reading the Vaxcyte, Inc. forecast
The PCVX targets sit in a narrow band, from $120.00 to $125.00, around an average of $122.33.
Set next to the $63.37 PCVX quote, that average is +93.0%.
Ratings on the Vaxcyte, Inc. cluster: 10 of 11 analysts are on the buy side, 1 is at hold, and 0 are on the sell side, and the published consensus is Buy.
PCVX targets have not moved much: $122.33 recently, $122.33 across the quarter.
Only 11 analysts cover PCVX, so the average rests on a short list.
Vaxcyte, Inc. forecast questions
What is the PCVX price target?
The published range for PCVX is $120.00 to $125.00, with an average of $122.33. That average is +93.0% versus the current price of $63.37.
Is Vaxcyte, Inc. a buy or sell?
Of the 11 analysts covering Vaxcyte, Inc., 10 rate it a buy, 1 rates it a hold, and 0 rate it a sell. The consensus is Buy, and the PCVX headcount is 10 buy, 1 hold, and 0 sell.
What is the EPS estimate for Vaxcyte, Inc.?
Analyst EPS estimates for Vaxcyte, Inc.: 2026 $-8.23, 2027 $-6.50.
What is the revenue estimate for Vaxcyte, Inc.?
Analyst revenue estimates for Vaxcyte, Inc.: 2026 $25.00M, 2027 $87.15M.
How many analysts cover PCVX?
11 analysts cover PCVX. Their consensus on PCVX is Buy, across those 11.